Timm H. Jessen

Chief Executive Officer & Founder at SCIENAMICS GmbH

Timm H. Jessen

Timm H. Jessen

Chief Executive Officer & Founder at SCIENAMICS GmbH

Overview
Career Highlights

Evotec SE
Topas Therapeutics GmbH
bionamics GmbH

RelSci Relationships

72

Number of Boards

3

Birthday

1962

Age

59

Contact Data
Trying to get in touch with Timm H. Jessen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Timm H. Jessen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head-Drug Design Department & Professor at University of Copenhagen

Relationship likelihood: Strong

Chief Executive Officer at Evotec SE

Relationship likelihood: Strong

Chief Operating Officer at Topas Therapeutics GmbH

Relationship likelihood: Strong

Chief Financial Officer at Vifor Pharma AG

Relationship likelihood: Strong

Former Chief Innovation Officer at Evotec SE

Relationship likelihood: Strong

Chief Executive Officer at Topas Therapeutics GmbH

Relationship likelihood: Strong

Founder at Artus GmbH Personaldienst

Relationship likelihood: Strong

Chief Executive Officer at DELTA, Dansk, Elektronik, Lys & Akustik

Relationship likelihood: Average

Co-Founder at Saniona AB

Relationship likelihood: Average

Chairman, Board of Directors at Nanovi Radiotherapy A/S

Relationship likelihood: Average

Paths to Timm H. Jessen
Potential Connections via
Relationship Science
You
Timm H. Jessen
Chief Executive Officer & Founder at SCIENAMICS GmbH
Career History
Chief Executive Officer & Founder
2004 - Current

SCIENAMICS GmbH offers services for life science companies in the area of scientific marketing, business development and strategic consulting. It offers services for public Sector, academia, investors, pharma and biotech companies. The company was founded by Timm H. Jessen on July 1, 2004 and is headquartered in Schleswig, Germany.

Chief Executive Officer
2015 - 2020

Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.

Co-Founder
2006 - Prior

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

Boards & Committees
Member-Supervisory Board
Prior
Investments
Details Hidden

Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.

Details Hidden

DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes.DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Timm H. Jessen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Timm H. Jessen's profile does not indicate a business or promotional relationship of any kind between RelSci and Timm H. Jessen.